论文部分内容阅读
目的:观察舍曲林治疗脑梗死后焦虑抑郁患者的疗效。方法:脑梗死后焦虑抑郁患者60例,随机分为两组,每组30例,治疗组每日给予盐酸舍曲林治疗,对照组每日给予阿普唑仑片、谷维素片治疗,疗程8周,比较两组治疗前后汉密顿焦虑抑郁量表评分,神经功能缺损评分,生活能力评分。结果:治疗8周后两组患者的焦虑抑郁症状均明显好转,汉密顿焦虑抑郁评分、神经功能缺损评分明显降低,日常生活能力评分明显增高,但治疗组疗效明显优于对照组(P<0.01)。结论:盐酸舍曲林治疗脑梗死后焦虑抑郁疗效明显,并改善生活质量和神经功能缺损情况。
Objective: To observe the effect of sertraline on patients with anxiety and depression after cerebral infarction. Methods: Sixty patients with anxiety and depression after cerebral infarction were randomly divided into two groups (n = 30 in each group). The treatment group was given sertraline hydrochloride daily, while the control group was given alprazolam tablets and oryzanol tablets daily for 8 Weeks, Hamilton anxiety and depression scale score, neurological deficit score and life ability score before and after treatment were compared. Results: After 8 weeks of treatment, the symptoms of anxiety and depression in both groups were significantly improved. The depression score of anxiety, neurological deficit score and the score of daily living ability were significantly higher in treatment group than those in control group (P < 0.01). Conclusion: Sertraline hydrochloride has obvious curative effect on anxiety and depression after cerebral infarction, and improves quality of life and neurological deficit.